Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile

Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
117 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Bayer AG (Bayer) carries out the development, production and commercialization of healthcare products, nutritional supplements and specialty materials. The product portfolio of the company comprises animal health products, consumer care products, medical care products, pharmaceuticals, fungicides, insecticides, herbicides, polyurethanes, polycarbonates, coatings, adhesives and specialties. It caters to pharmaceutical, agricultural and polymer industries. Bayer also operates radiology business unit that markets contrast-enhanced diagnostic imaging equipment jointly with the necessary contrast agents.

Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rati

  
Source:
Document ID
GDME40270D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents26
  List of Tables52
  List of Figures71
Bayer AG, Medical Equipment, Deals By Year, 2010 to YTD 201672
Bayer AG, Medical Equipment Deals By Type, 2010 to YTD 201691
Bayer AG, Medical Equipment, Deals By Region, 2010 to YTD 2016101
Bayer AG, Medical Equipment, Deals By Market, 2010 to YTD 2016111
Bayer AG, Medical Equipment, Deals Summary, 2010 to YTD 2016123
Bayer AG, Medical Equipment, Deal Details1551
  Partnerships151
    Bayer Enters into Licensing Agreement with DelSiTech151
    ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology161
    MEDRAD Enters Into Licensing Agreement With B. Braun Melsungen171
    T2 Biosystems Enters into R&D Agreement with Bayer181
    Genedata Enters into Co-Development Agreement with Bayer Pharma191
    Ventana Extends Co-Development Agreement With Bayer Pharma201
    Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare211
    Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System221
    Bayer HealthCare Enters Into Agreement With Medsintez231
    Qiagen Enters Into Agreement With Bayer HealthCare To Develop Diagnostics Test In Oncology241
    Bayer HealthCare Enters Into Co-Marketing Agreement With Radimetrics For eXposure251
    Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device261
    Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma271
    Bayer Vital Signs Agreement With Vital Images281
    Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare292
    HANDOK Pharma Enters Into Co-Marketing Agreement With Bayer Korea311
    Cancer Targeted Enters Into Research And License Option Agreement With Bayer Pharma321
    Bayer Schering Pharma Enters Into An Agreement With National Pharma Engineering Research Center331
    MEDRAD Enters Into A Distribution Agreement With WFR-AQUAPLAST And Qfix Systems341
    Bayer Schering Pharma Enters Into An Agreement With Protagen351
    TauRx Pharma Enters Into Co-development Agreement With Bayer Schering Pharma361
    Prometheus Labs Signs Licensing Agreement With Bayer Schering Pharma371
  Debt Offering381
    Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075381
    Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million391
    Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075402
    Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074422
    Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016441
    Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018451
    Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021461
    Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million471
    Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million481
    Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million491
    Bayer Holding Completes Public Offering Of 1.46% Corporate Bonds Due 2017 For US$109 Million501
  Asset Transactions511
    Bayer May Sell Radiology Business511
    Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion522
    Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million541
    Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care551
    Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma561
    Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare571
    VisEn Medical Acquires Fluorescent Imaging Intellectual Property From Bayer Schering Pharma581
  Acquisition591
    Bayer May Acquire Sirtex Medical591
    Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion602
    Bayer HealthCare To Acquire Radimetrics, Healthcare Software Maker621
    MEDRAD Completes Acquisition Of Pathway Medical Technologies For US$125 Million632
    Bayer MaterialScience Acquires Artificial Muscle651
Bayer AG - Key Competitors661
Key Employees673
Locations And Subsidiaries7011
  Head Office701
  Other Locations &Subsidiaries7011
Recent Developments811
Strategy And Business Planning811
Sep 20, 2016: Bayer sets ambitious growth and earnings aspirations812
Sep 18, 2015: Bayer aligns organization with Life Science businesses832
Aug 27, 2015: CINDE Announces: Bayer Opened Its First Medical Devices Plant in Costa Rica851
Feb 12, 2015: Bayer Initiates Life-Science Reorganization861
Financial Announcements871
Apr 26, 2016: Bayer Announces Interim report for the first quarter of 2016872
Oct 29, 2015: Bayer posts strong earnings growth893
Jul 29, 2015: Bayer Significantly Improves Earnings923
Apr 30, 2015: Strong start to the year for Bayer953
Mar 11, 2015: Bayer aspires to significantly expand Life Science businesses981
Feb 26, 2015: Bayer: strong business momentum continues and portfolio transformation underway993
Feb 25, 2015: Bayer proposes increased dividend for 2014 of EUR 2.25 per share1021
Research And Development1031
Jun 19, 2015: Bayer Plans To Invest 4 Billion In R&D In 20151031
Corporate Communications1041
Mar 23, 2016: Dr. Michael Preuss to be new head of Communications at Bayer1041
Feb 24, 2016: Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG1051
Feb 25, 2015: Dr. Richard Pott to be Chairman of the Supervisory Board of Bayer MaterialScience1061
Product News1071
Feb 29, 2016: FDA takes additional action to better understand safety of Essure, inform patients of potential risks1072
Other Significant Developments1091
Jul 27, 2016: Bayer raises sales and earnings1094
Apr 25, 2016: 2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner1131
Sep 15, 2015: New scholarships worth EUR 332,000 awarded by Bayer Foundation to promote international talents1141
May 27, 2015: Bayer has outstanding perspectives as a pure Life Science company1152
Appendix1171
  Methodology1171
  About GlobalData1171
  Contact Us1171
  Disclaimer1171

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 03, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Bayer-AG-BAYN-Medical-Equipment-Deals-and-Alliances-Profile-2148-17539>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Bayer AG (BAYN) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Bayer-AG-BAYN-Medical-Equipment-Deals-and-Alliances-Profile-2148-17539>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research